Takeda Masayuki 武田真幸

… Alternative Names

TAKEDA Masayuki 武田真幸

Less

Researcher Number	20510928
Other IDs
Affiliation (Current)	2025: 奈良県立医科大学, 医学部, 教授
Affiliation (based on the past Project Information) *help	2024: 奈良県立医科大学, 医学部, 教授 2021: 奈良県立医科大学, 医学部, 教授 2019 – 2020: 近畿大学, 医学部, 講師 2017: 近畿大学, 医学部, 助教 2015 – 2017: 近畿大学, 医学部, 講師
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Tumor therapeutics Except Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator 次世代シーケンサー（NGS） / 薬物治療アクセス割合 / 機能解析 / VUS / 次世代シーケンサー / 肺癌 / ドライバー遺伝子 / 遺伝子パネル / 分子標的治療 / 薬効評価と予測 … More Except Principal Investigator … More SCID / PDX / immunotherapy / antibody / HLA-F Less

Basic research into the practical application of immunotherapy targeting the novel immune checkpoint molecule HLA-F
- Principal Investigator
  
  王寺典子 (下嶋典子)
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Nara Medical University
Functional analysis of novel gene mutation identified in clinical sequencingPrincipal Investigator
- Principal Investigator
  
  Takeda Masayuki
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Nara Medical University
  Kindai University
Mechanism of driver mutation positive lung cancerPrincipal Investigator
- Principal Investigator
  
  TAKEDA Masayuki
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Kindai University

All 2022 2021 2020 2019 2017 2016 2015

All Journal Article Presentation

[Journal Article] Yolk Sac Tumor in a Recurrence of Colonic Adenocarcinoma With Shared Mutations in <i>APC</i> and <i>TP53</i> Genes: A Case Report2022
- Author(s)
  Otani Tomoyuki、Kanemura Hiroaki、Kimura Masatomo、Mitani Seiichiro、Takeda Masayuki、Matsuki Mitsuru、Matsumura Noriomi、Satou Takao、Nakagawa Kazuhiko、Ito Akihiko
- Journal Title
  
  International Journal of Surgical Pathology
  
  Volume: In press Issue: 6 Pages: 646-651
- DOI
  10.1177/10668969211069963
- Data Source
  KAKENHI-PROJECT-19K07721
[Journal Article] Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors2021
- Author(s)
  Takeda M, Takahama T, Sakai K, Shimizu S, Watanabe S, Kawakami H, Tanaka K, Sato C, Hayashi H, Nonagase Y, Yonesaka K, Takegawa N, Okuno T, Yoshida T, Fumita S, Suzuki S, Haratani K, Saigoh K, Ito A, Mitsudomi T, Handa H, Fukuoka K, Nakagawa K, Nishio K.
- Journal Title
  
  Oncologist
  
  Volume: 26(4) Issue: 4 Pages: e588-e596
- DOI
  10.1002/onco.13639
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07721
[Journal Article] Current Status of Next-Generation Sequencing-Based Cancer Genome Profiling Tests in Japan and Prospects for Liquid Biopsy2021
- Author(s)
  Yoshii Yumi、Okazaki Shunsuke、Takeda Masayuki
- Journal Title
  
  Life
  
  Volume: 11 Issue: 8 Pages: 796-796
- DOI
  10.3390/life11080796
- Data Source
  KAKENHI-PROJECT-19K07721
[Journal Article] Successful treatment of a case of hormone receptor?positive metastatic extramammary Paget disease with tamoxifen2021
- Author(s)
  Isomoto Kohsuke、Haratani Koji、Watanabe Satomi、Takeda Masayuki、Iwasa Tsutomu、Nakagawa Kazuhiko
- Journal Title
  
  Investigational New Drugs
  
  Volume: 40 Issue: 1 Pages: 194-197
- DOI
  10.1007/s10637-021-01168-5
- Data Source
  KAKENHI-PROJECT-19K07721
[Journal Article] Impact of coexisting gene mutations in EGFR-mutated non-small cell lung cancer before treatment on EGFR T790M mutation status after EGFR-TKIs.2020
- Author(s)
  Takeda M, Sakai K, Hayashi H, Tanaka K, Haratani K, Takahama T, Kato R, Yonesaka K, Nishio K, Nakagawa K.
- Journal Title
  
  Lung Cancer
  
  Volume: 139 Pages: 28-34
- DOI
  10.1016/j.lungcan.2019.10.028
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K07721
[Journal Article] Toxicity profile of epidermal growth factor receptor tyrosine kinase inhibitors in patients with epidermal growth factor receptor gene mutation-positive lung cancer.2017
- Author(s)
  Takeda M, Nakagawa K.
- Journal Title
  
  Mol Clin Oncol
  
  Volume: 6 Issue: 1 Pages: 3-6
- DOI
  10.3892/mco.2016.1099
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K21525
[Journal Article] Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease.2016
- Author(s)
  Watanabe S, Takeda M, Takahama T, Iwasa T, Tsurutani J, Tanizaki J, Shimizu T, Sakai K, Wada Y, Isogai N, Nishio K, Nakagawa K.
- Journal Title
  
  Invest New Drugs.
  
  Volume: Feb 9
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-15K21525
[Journal Article] Genome sequencing for nonsmall-cell lung cancer identifies a basis for nintedanib sensitivity.2016
- Author(s)
  Takeda M, Sakai K, Okamoto K, Hayashi H, Tanaka K, Shimizu T, Nishio K, Nakagawa K.
- Journal Title
  
  Ann Oncol
  
  Volume: 27(4) Issue: 4 Pages: 748-750
- DOI
  10.1093/annonc/mdw021
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-15K21525
[Journal Article] Clinical application of amplicon-based next-generation sequencing to therapeutic decision making in lung cancer.2015
- Author(s)
  Takeda M, Sakai K, Terashima M, Kaneda H, Hayashi H, Tanaka K, Okamoto K, Takahama T, Yoshida T, Iwasa T, Shimizu T, Nonagase Y, Kudo K, Tomida S, Mitsudomi T, Saigo K, Ito A, Nakagawa K, Nishio K.
- Journal Title
  
  Ann Oncol
  
  Volume: 26(12) Issue: 12 Pages: 2477-2482
- DOI
  10.1093/annonc/mdv475
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-15K21525
[Journal Article] Role of EGFR Monoclonal Antibodies in the Management of Non-small Cell Lung Cancer.2015
- Author(s)
  Takeda M, Nakagawa K.
- Journal Title
  
  Curr Cancer Drug Targets
  
  Volume: 15(9) Pages: 792-802
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-15K21525
[Presentation] Clinical Application of the FoundationOne Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors2021
- Author(s)
  Takeda Masayuki, Takahama Takayuki, Sakai Kazuko, Shimizu Shigeki, Watanabe Satomi, Kawakami Hisato, Tanaka Kaoru, Fukuoka Kazuya, Nakagawa Kazuhiko, Nishio Kazuto
- Organizer
  第18回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-19K07721
[Presentation] Impact of Co-Mutations in EGFR-Mutated NSCLC Before EGFR-TKIs on T790M Mutation Status After TKIs2019
- Author(s)
  武田真幸,坂井和子,林秀敏,田中薫,原谷浩司,高濱隆幸,加藤了資,米阪仁雄,西尾和人,中川和彦
- Organizer
  日本肺癌学会
- Data Source
  KAKENHI-PROJECT-19K07721
[Presentation] 希少がんの新治療法確立に向けての課題2016
- Author(s)
  武田真幸
- Organizer
  第54回日本癌治療学会学術集会
- Place of Presentation
  パシフィコ横浜(横浜)
- Year and Date
  2016-10-20
- Data Source
  KAKENHI-PROJECT-15K21525

1. 西尾和人 (10208134)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
2. 坂井和子 (20580559)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
3. 王寺典子 (30398432)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Takeda Masayuki 武田 真幸

TAKEDA Masayuki 武田 真幸

Research Projects

Research Products

Co-Researchers

Basic research into the practical application of immunotherapy targeting the novel immune checkpoint molecule HLA-F

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Functional analysis of novel gene mutation identified in clinical sequencingPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Mechanism of driver mutation positive lung cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Yolk Sac Tumor in a Recurrence of Colonic Adenocarcinoma With Shared Mutations in <i>APC</i> and <i>TP53</i> Genes: A Case Report2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Current Status of Next-Generation Sequencing-Based Cancer Genome Profiling Tests in Japan and Prospects for Liquid Biopsy2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Successful treatment of a case of hormone receptor?positive metastatic extramammary Paget disease with tamoxifen2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Impact of coexisting gene mutations in EGFR-mutated non-small cell lung cancer before treatment on EGFR T790M mutation status after EGFR-TKIs.2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Toxicity profile of epidermal growth factor receptor tyrosine kinase inhibitors in patients with epidermal growth factor receptor gene mutation-positive lung cancer.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease.2016

Author(s)

Journal Title

Data Source

[Journal Article] Genome sequencing for nonsmall-cell lung cancer identifies a basis for nintedanib sensitivity.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical application of amplicon-based next-generation sequencing to therapeutic decision making in lung cancer.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Role of EGFR Monoclonal Antibodies in the Management of Non-small Cell Lung Cancer.2015

Author(s)

Journal Title

Data Source

[Presentation] Clinical Application of the FoundationOne Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors2021

Author(s)

Organizer

Data Source

[Presentation] Impact of Co-Mutations in EGFR-Mutated NSCLC Before EGFR-TKIs on T790M Mutation Status After TKIs2019

Author(s)

Organizer

Data Source

[Presentation] 希少がんの新治療法確立に向けての課題2016

Takeda Masayuki 武田真幸

TAKEDA Masayuki 武田真幸